C3 and diabetic kidney disease: Although the relevance of CXCL6 has been validated in in vitro using a human podocyte cell line [98] and in kidney biopsies and resections [97], the role of C3 in remains poorly characterized in kidney tissue from patients with diabetic nephropathy.